Balance Sheet HeartFlow, Inc.

Equities

HTFL

US42238D1072

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 06/03/2026 GMT			5-day change	1st Jan Change
22.98 ^USD	-7.56%		-0.78%	-21.17%

03-03	HeartFlow, Inc. Presents at Morgan Stanley Technology, Media & Telecom Conference 2026, Mar-03-2026 10:45 AM
02-18	Heartflow Insider Sold Shares Worth $1,595,486, According to a Recent SEC Filing	MT

5a8b5f.ZciydrfbWbMTXrgtWmLg7TXQqApTrjQJHgXtHOaKQmg.LKP3LMeDKPhhNfl1LDOjpAHj_F5j3AJsVnCuKqDPexEdicdHgOoY2GcHiA

Published financial data: HEARTFLOW, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2023	2024
Revenues	87.17M	126M
Total Revenues	87.17M	126M
Cost of Goods Sold, Total	29.12M	31.36M
Gross Profit	58.05M	94.45M
Selling General & Admin Expenses, Total	95.11M	112M
R&D Expenses	35.85M	43.52M
Other Operating Expenses, Total	131M	156M
Operating Income	-72.91M	-61.22M
Interest Expense, Total	-24.69M	-22.77M
Interest And Investment Income	5.46M	4.07M
Net Interest Expenses	-19.24M	-18.7M
Other Non Operating Income (Expenses)	2.16M	-16.45M
EBT, Excl. Unusual Items	-89.99M	-96.37M
Other Unusual Items	-5.12M	-
EBT, Incl. Unusual Items	-95.11M	-96.37M
Income Tax Expense	547K	53K
Earnings From Continuing Operations	-95.66M	-96.43M
Net Income to Company	-95.66M	-96.43M
Net Income - (IS)	-95.66M	-96.43M
Preferred Dividend and Other Adjustments	28.03M	-
Net Income to Common Incl Extra Items	-124M	-96.43M
Net Income to Common Excl. Extra Items	-124M	-96.43M
Per Share Items
Net EPS - Basic	-25.32	-17.98
Basic EPS - Continuing Operations	-25.32	-17.98
Basic Weighted Average Shares Outstanding	4.89M	5.36M
Net EPS - Diluted	-25.32	-17.98
Diluted EPS - Continuing Operations	-25.32	-17.98
Diluted Weighted Average Shares Outstanding	4.89M	5.36M
Normalized Basic EPS	-11.51	-11.23
Normalized Diluted EPS	-11.51	-11.23
Supplemental Items
EBITDA	-71.37M	-59.56M
EBITA	-72.91M	-61.22M
EBIT	-72.91M	-61.22M
EBITDAR	-65.34M	-53.07M
Effective Tax Rate - (Ratio)	-0.58	-0.05
Normalized Net Income	-56.24M	-60.23M
Supplemental Operating Expense Items
Advertising Expense	778K	1.54M
Research And Development Expense From Footnotes	35.85M	43.52M
Net Rental Expense, Total	6.03M	6.5M
Imputed Operating Lease Interest Expense	-	7.37M
Imputed Operating Lease Depreciation	-	-876K
Stock-Based Comp., COGS (Total)	440K	307K
Stock-Based Comp., R&D Exp. (Total)	3.34M	2.15M
Stock-Based Comp., SG&A Exp. (Total)	8.72M	7.76M
Total Stock-Based Compensation	12.5M	10.21M

Fiscal Period: December	2023	2024
Assets
Cash And Equivalents	123M	51.37M
Total Cash And Short Term Investments	123M	51.37M
Accounts Receivable, Total	22.5M	27.09M
Total Receivables	22.5M	27.09M
Prepaid Expenses	3.18M	3.02M
Restricted Cash	-	150K
Other Current Assets, Total	-	662K
Total Current Assets	148M	82.29M
Gross Property Plant And Equipment	81.55M	79.22M
Accumulated Depreciation	-50.66M	-51.49M
Net Property Plant And Equipment	30.88M	27.72M
Accounts Receivable Long-Term	988K	3.7M
Deferred Charges Long-Term	-	413K
Other Long-Term Assets, Total	4.73M	4.58M
Total Assets	185M	119M
Liabilities
Accounts Payable, Total	2.89M	2.87M
Accrued Expenses, Total	19.17M	21.83M
Current Portion of Leases	5.14M	5.42M
Unearned Revenue Current, Total	2.11M	1.04M
Other Current Liabilities	3.51M	2.45M
Total Current Liabilities	32.82M	33.6M
Long-Term Debt	134M	136M
Long-Term Leases	21.45M	18.54M
Other Non Current Liabilities	5.77M	21.05M
Total Liabilities	194M	210M
Preferred Stock Convertible	769M	769M
Total Preferred Equity	769M	769M
Common Stock, Total	14K	18K
Additional Paid In Capital	97.46M	112M
Retained Earnings	-875M	-971M
Comprehensive Income and Other	-501K	-772K
Total Common Equity	-778M	-859M
Total Equity	-9M	-90.92M
Total Liabilities And Equity	185M	119M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.94M	6.12M
ECS Total Common Shares Outstanding	4.94M	6.12M
Book Value / Share	-157.37	-140.39
Tangible Book Value	-778M	-859M
Tangible Book Value Per Share	-157.37	-140.39
Total Debt	161M	160M
Net Debt	37.83M	109M
Debt Equivalent Oper. Leases	48.21M	51.98M
Account Code - Inventory Valuation	3	3
Machinery, Total	9.94M	5.72M
Full Time Employees	-	626
Accumulated Allowance for Doubtful Accounts (Supple)	1.06M	814K

Fiscal Period: December	2023	2024
Net Income	-95.66M	-96.43M
Depreciation & Amortization - CF	4.43M	4.39M
Depreciation & Amortization, Total	4.43M	4.39M
Amortization of Deferred Charges, Total - (CF)	6.84M	5.31M
Stock-Based Compensation (CF)	11.87M	10.21M
Provision and Write-off of Bad Debts	1.19M	-244K
Other Operating Activities, Total	144K	2.02M
Change In Accounts Receivable	-9.35M	-3.85M
Change In Accounts Payable	-623K	-327K
Change in Other Net Operating Assets	4.71M	9.91M
Cash from Operations	-76.43M	-69M
Capital Expenditure	-6.1M	-4.36M
Cash from Investing	-6.1M	-4.36M
Issuance of Common Stock	589K	4.56M
Repurchase of Common Stock	-228K	-
Issuance of Preferred Stock	169M	-
Other Financing Activities, Total	-	-2.33M
Cash from Financing	169M	2.24M
Foreign Exchange Rate Adjustments	-504K	-271K
Net Change in Cash	86.28M	-71.39M
Supplemental Items
Cash Interest Paid	20.8M	19.16M
Cash Income Tax Paid (Refund)	405K	-72K
Levered Free Cash Flow	-	-41.66M
Unlevered Free Cash Flow	-	-29.04M
Change In Net Working Capital	-	4.73M

Fiscal Period: December	2023	2024
Profitability
Return on Assets	-	-25.19
Return on Total Capital	-	-34.62
Return On Equity %	-	193.01
Return on Common Equity	-	11.78
Margin Analysis
Gross Profit Margin %	66.59	75.07
SG&A Margin	109.1	89.15
EBITDA Margin %	-81.87	-47.35
EBITA Margin %	-83.64	-48.66
EBIT Margin %	-83.64	-48.66
Income From Continuing Operations Margin %	-109.73	-76.65
Net Income Margin %	-109.73	-76.65
Net Avail. For Common Margin %	-141.89	-76.65
Normalized Net Income Margin	-64.52	-47.88
Levered Free Cash Flow Margin	-	-33.12
Unlevered Free Cash Flow Margin	-	-23.09
Asset Turnover
Asset Turnover	-	0.83
Fixed Assets Turnover	-	4.29
Receivables Turnover (Average Receivables)	-	5.07
Short Term Liquidity
Current Ratio	4.52	2.45
Quick Ratio	4.43	2.33
Operating Cash Flow to Current Liabilities	-2.33	-2.05
Days Sales Outstanding (Average Receivables)	-	72.13
Average Days Payable Outstanding	-	33.6
Long Term Solvency
Total Debt/Equity	-1.78K	-176.41
Total Debt / Total Capital	105.94	230.88
LT Debt/Equity	-1.73K	-170.45
Long-Term Debt / Total Capital	102.55	223.08
Total Liabilities / Total Assets	104.86	176.59
EBIT / Interest Expense	-2.95	-2.69
EBITDA / Interest Expense	-2.65	-2.33
(EBITDA - Capex) / Interest Expense	-2.89	-2.52
Total Debt / EBITDA	-2.46	-3.02
Net Debt / EBITDA	-0.58	-2.05
Total Debt / (EBITDA - Capex)	-2.25	-2.79
Net Debt / (EBITDA - Capex)	-0.53	-1.9
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	44.32
Gross Profit, 1 Yr. Growth %	-	62.7
EBITDA, 1 Yr. Growth %	-	-16.54
EBITA, 1 Yr. Growth %	-	-16.04
EBIT, 1 Yr. Growth %	-	-16.04
Earnings From Cont. Operations, 1 Yr. Growth %	-	0.81
Net Income, 1 Yr. Growth %	-	0.81
Normalized Net Income, 1 Yr. Growth %	-	7.1
Diluted EPS Before Extra, 1 Yr. Growth %	-	-28.99
Accounts Receivable, 1 Yr. Growth %	-	20.41
Net Property, Plant and Equip., 1 Yr. Growth %	-	-10.22
Total Assets, 1 Yr. Growth %	-	-35.85
Tangible Book Value, 1 Yr. Growth %	-	10.54
Common Equity, 1 Yr. Growth %	-	10.54
Cash From Operations, 1 Yr. Growth %	-	-9.72
Capital Expenditures, 1 Yr. Growth %	-	-28.63